Marshall Wace North America’s LeMaitre Vascular LMAT Stock Holding History

Marshall Wace North America’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12,068	Closed	-$488K	–	1653
2020 Q4	$488K	Buy	+12,068	New	+$431K	﹤0.01%	1088
2019 Q4	–	Sell	-13,790	Closed	-$473K	–	1454
2019 Q3	$473K	Sell	13,790 -41,488	-75%	-$1.33M	﹤0.01%	821
2019 Q2	$1.55M	Buy	55,278 +13,916	+34%	+$387K	0.01%	629
2019 Q1	$1.28M	Buy	+41,362	New	+$1.1M	0.01%	623
2018 Q4	–	Sell	-162,659	Closed	-$6.3M	–	1567
2018 Q3	$6.3M	Sell	162,659 -1,368	-0.8%	-$49.3K	0.04%	275
2018 Q2	$5.49M	Buy	164,027 +64,714	+65%	+$2.3M	0.03%	490
2018 Q1	$3.6M	Buy	+99,313	New	+$3.44M	0.02%	645
2017 Q2	–	Sell	-39,536	Closed	-$988K	–	1385
2017 Q1	$988K	Buy	+39,536	New	+$928K	0.01%	704

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

SCA

Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Marshall Wace North America's LMAT Position: Q1 2021 in Review

Marshall Wace North America sold out of LeMaitre Vascular (LMAT) in Q1 2021, closing a stake of 12,068 shares — an estimated $488K sold.

Marshall Wace North America first reported a position in LMAT in Q1 2017 and held it in 8 quarters. The position peaked at $6.3M in Q3 2018. 179 funds tracked by Wall St. Rank hold LMAT as of Q1 2021.

Marshall Wace North America reported no remaining LeMaitre Vascular position as of Q1 2021 after selling out during the quarter.
Marshall Wace North America sold 12,068 LeMaitre Vascular shares in Q1 2021, an estimated $488K.
Marshall Wace North America first reported a position in LeMaitre Vascular in Q1 2017 and held it in 8 quarters.
Marshall Wace North America's LeMaitre Vascular position peaked at $6.3M in Q3 2018.
179 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2021.

Based on Marshall Wace North America's 13F filing for Q1 2021, filed 17 May 2021.